The Business Research Company’s global market reports are now updated with the latest market sizing information for the year 2023 and forecasted to 2032

The Business Research Company’s vaccine adjuvants market report forecasts the vaccine adjuvants market size to grow to $2.38 Billion by 2027, with a CAGR (compound annual growth rate) of more than 7%.

Learn More On The Vaccine Adjuvants Market Report 2023 – https://www.thebusinessresearchcompany.com/report/vaccine-adjuvants-global-market-report

Vaccine Adjuvants Market Size Forecast
The global vaccine adjuvants market is expected to grow from $1.63 billion in 2022 to $1.77 billion in 2023 at a compound annual growth rate (CAGR) of 8.7%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The global vaccine adjuvants market size is expected to reach $2.38 billion in 2027 at a CAGR of 7.7%.

North America held the largest vaccine adjuvants market share, and Asia-Pacific was the fastest-growing region in 2022.

Key Vaccine Adjuvants Market Driver ­– Rise In The Prevalence Of Infectious Diseases
According to the World Health Organisation (WHO) forecast for 2022, an estimated 10.6 million people are infected with tuberculosis globally in 2021, 1.6 million die, and 1.5 million individuals get HIV in 2021, with 650,000 dying as a result. As a result, increased infectious illness prevalence will boost the vaccine adjuvants market.

Request for A Sample Of The Global Vaccine Adjuvants Market Report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=10121&type=smp

Key Vaccine Adjuvants Market Trend – Strategic Partnership
Many companies in the vaccine adjuvants market are looking for collaborations to boost their market position. For example, in October 2021, Dynavax Technologies, a biotech company based in the United States, cooperated with the United States Department of Defence to create an adjuvanted plague vaccine using Dynavax’s CpG 1018 adjuvant. Furthermore, in September 2020, Valneva SE, a biotech firm located in France, will collaborate with Dynavax, a biotech business based in the United States, to develop an adjuvant for the COVID-19 vaccine.

Vaccine Adjuvants Market Segment
1) By Product Type: Adjuvant Emulsions, Pathogen Components, Particulate Adjuvants, Combination Adjuvants, Other Product Types
2) By Route of Application: Human Vaccine Adjuvants, Veterinary Vaccine Adjuvants
3) By Route of Administration: Oral, Intramuscular, Intranasal, Subcutaneous, Intradermal
4) By Disease: Cancer, Infectious Diseases, Other Diseases

Vaccine Adjuvants Market Major Players and Strategies
Major players in the vaccine adjuvants market are GlaxoSmithKline Plc, Novavax, Inc, SPI Pharma, Agenus, Inc, CSL Limited, InvivoGen, Brenntag Biosector A/S, Adjuvatis, Merck KGaA, Croda International Plc, Seppic Inc, OZ Biosciences, Avanti Polar Lipids, Inc, Astellas Pharma Inc, Virometix AG, MPV Technologies Limited, and Adjuvance Technologies Inc.

GSK plc, a UK-based pharmaceutical and biotechnology business, paid $3.3 billion for Affinivax Inc. in August 2022. The acquisition of Affinivax adds to GSK’s objective of developing a large portfolio of specialised new medications and vaccines. It consists of a next-generation 24-valent pneumococcal vaccine adjuvant (AFX3772), which is now in phase II development and is based on the very groundbreaking Multiple Antigen Presenting System (MAPSTM) platform technology. Affinivax Inc. is a clinical-stage biopharmaceutical firm established in the United Kingdom that specialises in vaccination adjuvants.

The Vaccine Adjuvants Global Market Report 2023 covers regional data on vaccine adjuvants market size, vaccine adjuvants market trends and drivers, opportunities, strategies, and vaccine adjuvants market competitor analysis. The countries covered in the vaccine adjuvants market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, the UK, and the USA, and the major seven regions are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa.

Vaccine adjuvants are substances or ingredients used in vaccines to boost the body’s immunogenic response to antigens that lack immunostimulatory properties and aid in the development of a greater immune response.

View More Reports Related To The Vaccine Adjuvants Market –
Veterinary Vaccines Global Market Report 2023
Pediatric Vaccine Global Market Report 2023
Companion Animal Veterinary Vaccines Global Market Report 2023

Contact us at:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at [email protected]

Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on: